Literature DB >> 18348446

Sun exposure and cancer survival in Norway: changes in the risk of death with season of diagnosis and latitude.

Alina Carmen Porojnicu1, Arne Dahlback, Johan Moan.   

Abstract

Epidemiological and experimental studies suggest that derivatives of vitamin D may improve prognosis of a number of cancer types. Sun is our most important source of vitamin D. Seasonal variations and latitudinal gradients of calcidiol (the marker of vitamin D status) have been reported. We wanted to investigate if season and latitude play any role for survival from seven different cancer types in Norway. Seasonal and geographical variations of vitamin D were estimated by calculations and were compared with clinical data. For the survival analyses, 249373 cancer patients were followed for three years after diagnosis and the risk of death was analyzed separately for summer- and winter diagnosis, as well as for two geographical regions with different UV exposures. We found a 15-25% better survival for patients diagnosed during summer and a slight beneficial effect for residents of the high UV region for some of the cancer forms investigated. Based on our results we suggest that calcidiol concentration at the time of cancer diagnosis is related to survival and discuss briefly ways to improve the vitamin D levels in the general population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348446     DOI: 10.1007/978-0-387-77574-6_4

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  18 in total

1.  Low 25-hydroxyvitamin D levels in people with a solid tumor cancer diagnosis: the tip of the iceberg?

Authors:  Katherine Hauser; Declan Walsh; Shiva Shrotriya; Matthew Karafa
Journal:  Support Care Cancer       Date:  2014-02-28       Impact factor: 3.603

2.  Duration of vitamin D synthesis from weather model data for use in prospective epidemiological studies.

Authors:  Kåre Edvardsen; Ola Engelsen; Magritt Brustad
Journal:  Int J Biometeorol       Date:  2009-05-15       Impact factor: 3.787

3.  Vitamin D may reduce prostate cancer metastasis by several mechanisms including blocking Stat3.

Authors:  William B Grant
Journal:  Am J Pathol       Date:  2008-11       Impact factor: 4.307

4.  Prospective study of ultraviolet radiation exposure and mortality risk in the United States.

Authors:  Shih-Wen Lin; David C Wheeler; Yikyung Park; Michael Spriggs; Albert R Hollenbeck; D Michal Freedman; Christian C Abnet
Journal:  Am J Epidemiol       Date:  2013-07-17       Impact factor: 4.897

5.  The association between breast cancer prognostic indicators and serum 25-OH vitamin D levels.

Authors:  Luke J Peppone; Aaron S Rickles; Michelle C Janelsins; Michael R Insalaco; Kristin A Skinner
Journal:  Ann Surg Oncol       Date:  2012-03-24       Impact factor: 5.344

6.  The effect of season of operation on the survival of patients with resected non-small cell lung cancer.

Authors:  Akif Turna; Atilla Pekçolaklar; Muzaffer Metin; Ilhan Yaylim; Atilla Gurses
Journal:  Interact Cardiovasc Thorac Surg       Date:  2011-11-30

7.  The effect of various vitamin D supplementation regimens in breast cancer patients.

Authors:  Luke J Peppone; Alissa J Huston; Mary E Reid; Randy N Rosier; Yousef Zakharia; Donald L Trump; Karen M Mustian; Michelle C Janelsins; Jason Q Purnell; Gary R Morrow
Journal:  Breast Cancer Res Treat       Date:  2011-03-08       Impact factor: 4.872

8.  Time trends and latitude dependence of uveal and cutaneous malignant melanoma induced by solar radiation.

Authors:  Johan Moan; Emanuela Cicarma; Richard Setlow; Alina C Porojnicu; William B Grant; Asta Juzeniene
Journal:  Dermatoendocrinol       Date:  2010-01

9.  A critical review of Vitamin D and Cancer: A report of the IARC Working Group.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-01

10.  How strong is the evidence that solar ultraviolet B and vitamin D reduce the risk of cancer?: An examination using Hill's criteria for causality.

Authors:  William B Grant
Journal:  Dermatoendocrinol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.